The incidence of COVID-19-related hospitalisation in migrants in the UK: Findings from the Virus Watch prospective community cohort study

Background: Migrants in the UK may be at higher risk of SARS-CoV-2 exposure; however, little is known about their risk of COVID-19-related hospitalisation during waves 1-3 of the pandemic. Methods: We analysed secondary care data linked to Virus Watch study data for adults and estimated COVID-19-related hospitalisation incidence rates by migration status. To estimate the total effect of migration status on COVID-19 hospitalisation rates, we ran fixed-effect Poisson regression for wave 1 (01/03/2020-31/08/2020; wildtype), and fixed-effect negative binomial regressions for waves 2 (01/09/2020-31/05/2021; Alpha) and 3 (01/06/2020-31/11/2021; Delta). Results of all models were then meta-analysed. Results: Of 30,276 adults in the analyses, 26,492 (87.5%) were UK-born and 3,784 (12.5%) were migrants. COVID-19-related hospitalisation incidence rates for UK-born and migrant individuals across waves 1-3 were 2.7 [95% CI 2.2-3.2], and 4.6 [3.1-6.7] per 1,000 person-years, respectively. Pooled incidence rate ratios across waves suggested increased rate of COVID-19-related hospitalisation in migrants compared to UK-born individuals in unadjusted 1.68 [1.08-2.60] and adjusted analyses 1.35 [0.71-2.60]. Conclusions: Our findings suggest migration populations in the UK have excess risk of COVID-19-related hospitalisations and underscore the need for more equitable interventions particularly aimed at COVID-19 vaccination uptake among migrants.

[1]  A. Forster,et al.  Defining the determinants of vaccine uptake and undervaccination in migrant populations in Europe to improve routine and COVID-19 vaccine uptake: a systematic review , 2022, The Lancet Infectious Diseases.

[2]  S. Katikireddi,et al.  Migrants’ primary care utilisation before and during the COVID-19 pandemic in England: An interrupted time series analysis , 2022, The Lancet Regional Health - Europe.

[3]  M. Exline,et al.  Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study , 2022, BMJ.

[4]  A. Yavlinsky,et al.  Workplace contact patterns in England during the COVID-19 pandemic: Analysis of the Virus Watch prospective cohort study , 2021, The Lancet Regional Health - Europe.

[5]  R. Labonté,et al.  Safeguarding people living in vulnerable conditions in the COVID-19 era through universal health coverage and social protection , 2021, The Lancet Public Health.

[6]  G. Scally England’s new Office for Health Improvement and Disparities , 2021, BMJ.

[7]  A. Burdorf,et al.  1510Development and validation of a Job Exposure Matrix for work related risk factors for COVID-19 , 2021, International Journal of Epidemiology.

[8]  J. Kovář,et al.  Household overcrowding and risk of SARS-CoV-2: analysis of the Virus Watch prospective community cohort study in England and Wales , 2021, medRxiv.

[9]  K. Bhaskaran,et al.  Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform , 2021, The Lancet.

[10]  A. Majeed,et al.  Strategies and action points to ensure equitable uptake of COVID-19 vaccinations: A national qualitative interview study to explore the views of undocumented migrants, asylum seekers, and refugees , 2021, Journal of Migration and Health.

[11]  J. Carter,et al.  Impact of COVID-19 on migrants’ access to primary care and implications for vaccine roll-out: a national qualitative study , 2021, The British journal of general practice : the journal of the Royal College of General Practitioners.

[12]  S. Goldenberg,et al.  Sharpening our public health lens: advancing im/migrant health equity during COVID-19 and beyond , 2021, International Journal for Equity in Health.

[13]  D. Kriebel,et al.  COVID‐19 deaths by occupation, Massachusetts, March 1–July 31, 2020 , 2021, American journal of industrial medicine.

[14]  A. Majeed,et al.  Migration and Outbreaks of Vaccine-Preventable Disease in Europe: A Systematic Review , 2021, medRxiv.

[15]  M. Mckee,et al.  Clinical outcomes and risk factors for COVID-19 among migrant populations in high-income countries: A systematic review , 2020, Journal of Migration and Health.

[16]  S. Michie,et al.  Risk factors, symptom reporting, healthcare-seeking behaviour and adherence to public health guidance: protocol for Virus Watch, a prospective community cohort study , 2020, BMJ Open.

[17]  J. Pell,et al.  Occupation and risk of severe COVID-19: prospective cohort study of 120 075 UK Biobank participants , 2020, Occupational and Environmental Medicine.

[18]  J. Collins,et al.  Engaging the vulnerable: A rapid review of public health communication aimed at migrants during the COVID-19 pandemic in Europe , 2020, Journal of Migration and Health.

[19]  What is the impact of the COVID-19 pandemic on immigrants and their children? , 2020, OECD Policy Responses to Coronavirus (COVID-19).

[20]  Pia Hardelid,et al.  Data Resource Profile: Hospital Episode Statistics Admitted Patient Care (HES APC) , 2017, International journal of epidemiology.

[21]  G. Rezza,et al.  Vaccinations in migrants and refugees: a challenge for European health systems. A systematic review of current scientific evidence , 2017, Pathogens and global health.

[22]  Aziz Sheikh,et al.  Approaches to Recruiting 'Hard-To-Reach' Populations into Re-search: A Review of the Literature. , 2011, Health promotion perspectives.